Skip to content

Aura Biosciences, Inc. AURA Interest Income (Expense), after Provision for Loan Loss

Interest Income (Expense), after Provision for Loan Loss at other companies

Nelnet logo
NelnetNNI
$68.84M+38.5%
Truist Financial logo
Truist FinancialTFC
$3.12B+2.3%
USCB Financial Holdings, Inc. logo
USCB Financial Holdings, Inc.USCB
$21.25M+15.3%
BK
BKBK
$1.38B+20.7%
Fifth Third Bank logo
Fifth Third BankFITB
$1.71B+35.2%
Washington Trust Bancorp logo
Washington Trust BancorpWASH
$36.53M+3.7%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseAfterProvisionForLoanLoss.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s interest income (expense), after provision for loan loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s interest income (expense), after provision for loan loss?
Aura Biosciences, Inc. (AURA) reported interest income (expense), after provision for loan loss of $1.19M in Q1 2026.
How has Aura Biosciences, Inc.'s interest income (expense), after provision for loan loss changed year-over-year?
Aura Biosciences, Inc.'s interest income (expense), after provision for loan loss decreased by 25.3% year-over-year, from $1.59M to $1.19M.
What is the long-term trend for Aura Biosciences, Inc.'s interest income (expense), after provision for loan loss?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s interest income (expense), after provision for loan loss has grown at a 375.2% compound annual growth rate (CAGR), from $13K to $6.63M.